Emergency Department, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain.
Unitat de Salut Internacional Metropolitana Nord, Santa Coloma de Gramenet, Catalonia, Spain.
Malar J. 2017 Sep 11;16(1):365. doi: 10.1186/s12936-017-2007-5.
Malaria remains a major source of morbi-mortality among travellers. In 2007, a consensual multicenter Primary Care-Hospital shared guideline on travel-prior chemoprophylaxis, diagnosis and clinical management of imported malaria was set up in the Barcelona North Metropolitan area. The aim of the study is to assess the evolution of malaria cases in the area as well as its clinical management over the 10 years of its implementation.
A total of 190 malaria cases, all them imported, have been recorded. The overall estimated malaria crude incidence was of 0.47 cases per 10,000 population/year (95% CI 0.34-0.59) with a slight significant positive slope especially at the expense of an increase in Indian sub-continent Plasmodium vivax cases. The number of patients who attended the pre-travel consultation was low (13.7%) as well as those with prescribed chemoprophylaxis (10%). Severe malaria was diagnosed in 34 (17.9%) patients and ICU admittance was required in 2.6% of them. Organ sequelae (two renal failures and one post-acute distress respiratory syndrome) were recorded in 3 patients at hospital discharge, although all three were recovered at 30 days. None of the patients died. Patients complying with severity criteria were significantly males (p = 0.04), came from Africa (p = 0.02), were mainly non-immigrant travellers (p = 0.01) and were attended in a hospital setting (p < 0.001). The most frequently identified species was Plasmodium falciparum (64.2%), P. vivax (23.2%), Plasmodium malariae (1.6%) and Plasmodium ovale (1.1%). Those patients diagnosed with P. falciparum malaria came more often from sub-Saharan Africa (p < 0.001) and those with P. vivax came largely from the Indian sub-continent (p = 0.003). Among the 126 patients in whom an immunochromatographic antigenic test was performed, the result was interpreted as falsely negative in 12.1% of them. False negative results can be related to cases with <1% parasitaemia.
After 10 years of surveillance, a moderate increase in malaria incidence was observed, mostly P. vivax cases imported from the Indian sub-continent. Although severe malaria cases have been frequently reported, none of the patients died and organ sequelae were rare. Conceivably, the participation of the Primary Care and the District and Third Level Hospital professionals defining surveillance, diagnostic tests, referral criteria and clinical management can be considered a useful tool to minimize malaria morbi-mortality.
疟疾仍是旅行者发病和死亡的主要原因之一。2007 年,巴塞罗那北部大都市区建立了共识性的初级保健-医院共享指南,用于旅行前化学预防、诊断和临床管理输入性疟疾。本研究的目的是评估该地区疟疾病例的演变及其实施 10 年来的临床管理情况。
共记录了 190 例输入性疟疾病例。疟疾的粗发病率估计为 0.47 例/10000 人/年(95%CI 0.34-0.59),斜率略有显著正,尤其是由于印度次大陆间日疟原虫病例的增加。接受旅行前咨询的患者人数较少(13.7%),开预防药物的患者人数也较少(10%)。34 例(17.9%)患者诊断为重症疟疾,其中 2.6%需要入住 ICU。3 例患者出院时出现器官后遗症(2 例肾功能衰竭和 1 例急性呼吸窘迫综合征后),但所有 3 例患者在 30 天后均康复。无患者死亡。符合严重程度标准的患者显著为男性(p=0.04),来自非洲(p=0.02),主要是非移民旅行者(p=0.01),并在医院接受治疗(p<0.001)。最常见的疟原虫种是恶性疟原虫(64.2%)、间日疟原虫(23.2%)、卵形疟原虫(1.6%)和三日疟原虫(1.1%)。诊断为恶性疟原虫的患者更多来自撒哈拉以南非洲(p<0.001),而诊断为间日疟原虫的患者则主要来自印度次大陆(p=0.003)。在 126 例进行免疫层析抗原检测的患者中,结果在 12.1%的患者中被解释为假阴性。假阴性结果可能与<1%寄生虫血症的病例有关。
经过 10 年的监测,疟疾发病率呈中等程度上升,主要是来自印度次大陆的间日疟原虫输入性病例。尽管经常报告重症疟疾病例,但没有患者死亡,器官后遗症罕见。可以认为,初级保健和地区及三级医院专业人员参与监测、诊断试验、转诊标准和临床管理可以被视为降低疟疾发病和死亡的有用工具。